Summary & Overview
HCPCS Q4316: Amchoplast, Per Square Centimeter (Add-On)
HCPCS Level II code Q4316 represents Amchoplast billed per square centimeter as an add-on item to be reported in addition to a primary surgical procedure. This code captures the use of an implantable reconstructive material or adjunctive biomaterial applied during reconstructive, wound repair, or related surgical interventions. Nationally, accurately reporting add-on material codes like Q4316 matters for clinical documentation, inventory tracking, and payment clarity for procedures that require supplemental implantable products.
Key payers covered in this overview include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise explanation of the code’s clinical role and expected sites of service, plus what to expect when reconciling service lines that include per-square-centimeter billing for implantable materials. The publication outlines benchmarking context, common modifiers provided in the input, and areas where policy updates commonly affect coverage and billing practices. It also highlights how facilities typically report the code alongside primary surgical CPT or other procedure codes, and identifies where input data are not available for taxonomies, diagnosis pairings, and related codes. This summary is intended for billing professionals, revenue cycle managers, and clinicians needing a national-level reference for Q4316 reporting and administrative handling.
Billing Code Overview
HCPCS Level II code Q4316 describes Amchoplast billed per square centimeter, designated as an add-on procedure to be listed separately in addition to a primary procedure. The service type is implantable biomaterial/adjunctive reconstructive material used in surgical reconstruction or repair. The typical site of service is inpatient or outpatient surgical settings, including operating rooms and ambulatory surgical centers where reconstructive or wound repair procedures are performed.
Clinical & Coding Specifications
Clinical Context
A patient presents for augmentation or reconstruction of soft tissue defects requiring application of an amchoplast graft material charged by surface area. Typical patients are adults or adolescents with facial traumatic soft tissue loss, oncologic resection defects, or chronic nonhealing wounds where an adjunctive synthetic or biologic graft is applied to optimize contour and healing. The clinical workflow begins with preoperative evaluation by a surgeon (plastic, reconstructive, or ENT), determination that additional scaffold material is required beyond standard closure, measurement of the defect in square centimeters, and intraoperative application of the amchoplast product to the wound bed. The product is billed as an add-on supply per square centimeter using Q4316 in addition to the primary procedure code for the definitive repair (for example, primary closure, flap, or graft procedure). Intraoperative documentation includes defect dimensions, product brand and amount applied (cm2), implantation technique, and any modifiers reflecting unusual circumstances, anesthesia, or site of service. Postoperative care follows standard wound management and documentation of wound progress for subsequent visits.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
00 | No modifier | Use when no additional modifier applies and payer requests an explicit default modifier. |